Status:
UNKNOWN
Hepatitis C Patient Management and Family Health Education
Lead Sponsor:
China Liver Health
Collaborating Sponsors:
Peking University
Conditions:
Hepatitis C
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
INTRODUCTION: Hepatitis C virus (HCV) is recognized as the leading cause of chronic liver disease worldwide. However, the screening rate and treatment rate of HCV-infected patients in China is low, wh...
Eligibility Criteria
Inclusion
- Permanent residents in the province
- Ages 18-69 (inclusive)
- Both blood anti-HCV test and HCV-RNA test is positive
- Familiar with the use of mobile phones and WeChat
- Informed consent and voluntary participation in the study
Exclusion
- Temporary staff who come to the city to work, travel or visit relatives, or those who will be living in other cities for a long time
- Suffering from other serious diseases
- Patients with mental disorder or memory disorder
- Pregnant women or those who have a plan to prepare for pregnancy within one year
- Refuse to participate in the investigation
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03813498
Start Date
January 1 2019
End Date
November 1 2019
Last Update
January 23 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.